Manchester Royal Eye Hospital proudly stands as the pioneering healthcare institution in the United Kingdom to integrate Canon’s state-of-the-art ultra-wide field Xephilio OCT-S1 angiography machine directly into patient care settings. This groundbreaking achievement is made possible through the acquisition of the Widefield OCT A machine from Canon, a technological marvel that has the potential to revolutionize ophthalmic practices.
The acquisition of this cutting-edge technology is attributed to the generous support of charitable funds provided by the Manchester Foundation Trust Charity. This charitable organization plays a crucial role in advancing healthcare initiatives across the trust’s expansive network of ten hospitals, fostering progress and innovation in patient care.
Professor of Ophthalmology and Consultant Ophthalmologist, Tariq Aslam, underscores the profound impact of this new equipment on elevating the standard of patient care. He emphasizes the transformative nature of the technology, stating, “With this new equipment, we can significantly enhance patient care by providing immediate scans with the simplicity of capturing a picture. This capability allows for the early detection of potentially sight-threatening diseases, enabling our clinicians to make rapid diagnoses across a spectrum of conditions. Ultimately, this technological advancement empowers us to proactively prevent and treat the most common forms of sight loss.”
In essence, the deployment of Canon’s ultra-wide field Xephilio OCT-S1 angiography machine at Manchester Royal Eye Hospital not only signifies a technological leap in ophthalmology but also reflects the dedication of the medical community to advancing patient care through innovative solutions. The collaboration between healthcare institutions and charitable foundations serves as a testament to the collective commitment to progress, ensuring that cutting-edge technologies reach the forefront of patient-facing healthcare settings.